Candidiasis

Isolate submission REQUIRED for confirmed, suspected, and "rule-out" Candida auris isolates (any specimen source) 

Isolates received on the same patient will have antifungal susceptibility testing performed once every 30 days (based on the date of collection) unless it is a different organism or is requested by a healthcare provider in response to treatment failure.

TDH DLS Requisition:  PH-4182 Clinicial Submission Form 

Patient Preparation

• None

• Culture isolates on Sabouraud's agar or other appropriate media in screw capped tube.

-  Candida species other than C. albicans from any specimen source, especially                invasive sites

-  Yeast isolates from any specimen source when unable to identify species after            identification was attempted

• Specimen must be labeled with at least two unique patient identifiers and match accompanying PH-4182 Clinicial Submission Form.

• None

• Store samples at ambient temperature prior to shipment.

• Ship specimens at ambient temperature.
• All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 

• Unsatisfactory specimens include, but may not be limited to:-  

-  Damaged or visible leakage of transport tubes/plates.

-  Specimens without an accompanying PH-4182 Clinicial Submission Form

- Specimen does not have two unique identifiers.

• Specimens received that do not meet the specimen requirements outlined in the Directory of Services or that deviate from the special instructions will not be acceptable for testing.

• Nashville